Minimally-Invasive Glaucoma Surgery
Minimally Invasive Glaucoma Surgery (MIGS) is a modern group of surgical techniques designed to lower eye pressure in patients with glaucoma using very small incisions and highly specialized micro-devices.
Dr. Manolette Roque | Dr. Barbara Roque
St. Luke’s Medical Center – Global City
2nd Floor, Units 217-218, Roque Eye Clinic, Medical Arts Building
Rizal Drive cor. 5th Ave, Taguig City 1634, Philippines
+63-917-844-2020
+63-998-998-2020
+63-2-8828-2020
+63-2-8789-7700 ext. 7217
+63-2-8789-7700 ext. 7218
Dr. Manolette Roque | Dr. Barbara Roque
Asian Hospital and Medical Center
5th Floor, Unit 509, Roque Eye Clinic, Medical Office Building
2205 Civic Drive, Alabang, Muntinlupa City 1781, Philippines
+63-917-795-2020
+63-998-997-2020
+63-2-8771-9253
+63-2-8771-9000 ext. 7509
Minimally-Invasive Glaucoma Surgery
OVERVIEW
Minimally Invasive Glaucoma Surgery (MIGS) is a modern group of surgical techniques designed to lower eye pressure in patients with glaucoma using very small incisions and highly specialized micro-devices. Glaucoma damages the optic nerve when fluid pressure inside the eye stays too high. Therefore, controlling eye pressure remains the only proven way to slow or prevent vision loss. MIGS procedures improve fluid outflow with less tissue disruption than traditional glaucoma surgery. As a result, recovery is usually faster and more comfortable for properly selected patients.
WHO MAY BENEFIT
MIGS may benefit patients with mild to moderate glaucoma who need better pressure control despite medications or laser treatment. In many cases, surgeons combine MIGS with cataract surgery to improve efficiency and convenience. However, suitability depends on eye anatomy, glaucoma severity, prior surgeries, and target pressure goals. Therefore, a comprehensive glaucoma evaluation is required before recommending any procedure.
HOW MIGS WORKS
MIGS procedures lower intraocular pressure by enhancing the eye’s natural drainage pathways or by creating controlled new outflow routes. Surgeons use microscopic instruments and real-time visualization through the natural drainage angle of the eye. Because the approach is tissue-sparing, the risk profile is generally lower than traditional filtering surgery. Moreover, many techniques preserve future treatment options if additional control becomes necessary.
KEY FEATURES AND ADVANTAGES
Compared with conventional glaucoma surgery, MIGS offers several practical advantages for appropriate candidates. In addition, these features support earlier surgical intervention when indicated.
1. Small incisions and minimal tissue trauma.
2. Shorter surgical time and faster visual recovery.
3. Favorable safety profile in properly selected patients.
4. Often reduces the number of required glaucoma medications.
5. Can be combined with cataract surgery in one session.
LIMITATIONS AND CONSIDERATIONS
Although MIGS improves safety and recovery, it does not replace traditional glaucoma surgery in all cases. For example, patients with advanced glaucoma or very high target pressure reduction needs may still require more intensive procedures. Outcomes vary depending on device type, technique, and individual healing response. Therefore, realistic expectations and regular follow-up remain essential after surgery.
SAFETY AND EVIDENCE BASIS
Peer-reviewed clinical studies and long-term follow-up data support the safety and pressure-lowering effect of several MIGS techniques and devices. Furthermore, professional practice guidelines recognize MIGS as a valid option for selected glaucoma patients. Nevertheless, all eye surgeries carry risk. Possible complications include temporary pressure fluctuations, bleeding, inflammation, device malposition, or need for additional treatment.
CONSULTATION AND NEXT STEPS
A glaucoma specialist should perform a full diagnostic workup before recommending MIGS. This evaluation includes pressure measurement, optic nerve assessment, visual field testing, and imaging. Afterward, your surgeon will explain the most suitable options, expected benefits, and alternatives. Early evaluation and timely treatment improve the chance of preserving long-term vision.
Related products
-
MIGS iStent Inject
₱ 120,000.00 -
Phacoemulsification Cataract Surgery – CONTEMPORARY
₱ 150,000.00Original price was: ₱ 150,000.00.₱ 140,000.00Current price is: ₱ 140,000.00. -
Phacoemulsification Cataract Surgery – CORE
₱ 100,000.00 -
Pterygium Excision
₱ 35,000.00Original price was: ₱ 35,000.00.₱ 25,000.00Current price is: ₱ 25,000.00. -
Strabismus Surgery
₱ 70,000.00Original price was: ₱ 70,000.00.₱ 50,000.00Current price is: ₱ 50,000.00. -
Bevacizumab (AVASTIN) Anti-VEGF Intravitreal Injection
₱ 35,000.00Original price was: ₱ 35,000.00.₱ 25,000.00Current price is: ₱ 25,000.00.









